Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

pembrolizumab 78 Fulvestrant 76 Carboplatin 74 Trastuzumab 71 Capecitabine 69 Letrozole 62 Cyclophosphamide 61 Paclitaxel 60 pertuzumab 52 Specimen Handling 52 Docetaxel 50 abemaciclib 46 ribociclib 44 Anastrozole 35 130-nm albumin-bound paclitaxel 35 trastuzumab deruxtecan 34 Magnetic Resonance Spectroscopy 33 Blood Specimen Collection 33 Tamoxifen 32 sacituzumab govitecan 31 exemestane 31 Biopsy 31 Gemcitabine 30 Epirubicin 29 pyrotinib 28 palbociclib 28 Surveys and Questionnaires 27 Injections 27 Drug Therapy 27 eribulin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Isovaleryl-CoA Dehydrogenase × Breast × Clear all

NCT07281001 2025-12-15

Traderrus

Blokhin's Russian Cancer Research Center

Phase NA Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡